Actively Recruiting
Evaluating the Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe): a Cluster Randomized Trial
Led by Seoul National University · Updated on 2024-11-27
360
Participants Needed
1
Research Sites
32 weeks
Total Duration
On this page
Sponsors
S
Seoul National University
Lead Sponsor
M
Ministry of Food and Drug Safety, Korea
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a mobile web platform called eDrugSafe to see if it can help adults who take multiple medications manage their medicines better. This study focuses on whether eDrugSafe can improve medication adherence, confidence in managing medications, quality of life, and reduce hospital visits. It also aims to find out if eDrugSafe is practical and accepted for use in real community pharmacy settings. Participants will be assigned to one of two groups based on their local pharmacy. One group will use the eDrugSafe platform, which provides electronic access to medication information through QR codes linked to prescriptions. The other group will use traditional paper methods for managing their medication information. The study lasts for six months, during which participants will use their assigned methods to manage medications. During the study, participants will complete surveys at the beginning, three months, and six months to measure medication adherence and confidence in medication management. Researchers will also assess quality of life, emergency room visits, and hospitalizations after six months. The study involves adults aged 18 to 79 who take multiple medications and have access to a personal electronic device.
CONDITIONS
Brief Title
Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 79 years
- Ability to speak and understand Korean
- Own a personal electronic device that can access mobile apps and web services over wireless internet
- Currently taking three or more medications, with at least one prescribed for 28 days or longer
- Provided direct consent to participate in the study
You will not qualify if you...
- Using any mobile web platform other than eDrugSafe for medication safety information after enrollment
- Do not consent to participate or withdraw consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants use either the eDrugSafe mobile web platform for medication management and access to electronic medicinal product information or continue with usual care methods for medication management.
Visits at baseline, 3 months, and 6 months
Trial Site Locations
Total: 1 location
1
Seoul National University
Seoul, Gwanak-gu, South Korea, 08826
Actively Recruiting
Research Team
J
Jung-Mi Oh, Pharm.D
D
Da Eun Lee, Master, Pharm.D
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here